Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Embryology and Anatomy
Arnold, M., Hager,G.: Funktionsentwicklung der Nebenniere beim Goldhamster: Elektronenmikroskopische Untersuchungen am Mark. Z. Zellforsch. 83, 117 (1967).
Elfvin, L. G.: The ultrastructure of the capillary fenestrae in the adrenal medulla of the rat. J. Ultrastruct. Res. 12, 687 (1965).
Elfvin, L. G.: The development of the secretory granules in the rat adrenal medulla. J. Ultrastruct. Res. 17, 45 (1967).
Elfvin, L. G.: Effects of reserpine on the surface structure of chromaffin cells in the rat adrenal medulla. J. Ultrastruct. Res. 21, 459 (1968).
Elfvin, L. G., Appelgren, L. E., Ullberg, S.: High resolution autoradiography of the adrenal medulla after injection of tritiated dihydroxyphenylalanine (DOPA). J. Ultrastruct. Res. 14, 277 (1966).
Hempel, K., Kraft, M.: Zum Brenzkatechinamin-Stoffwech- sel der Nebenniere. Licht- und elektronenmikroskopisch- autoradiographische Untersuchungen mit 3 H-Dopa an Mäusen, Z. Zellforsch. 85, 322 (1968).
Moppert, J.: Zur Uhrastruktur der phaeochromen Zellen im Nebennierenmark der Ratte. Z. Zellforsch. 74, 32 (1966 a).
Moppert, J.: Der intrazeUuläre Bildungsort der phaeochromen Granula im Nebennierenmark der Ratte. Z. Zellforsch. 74, 45 (1966b).
Stöhr, JR. P. H.: Lehrbuch der Histologie und der mikroskopischen Anatomie. Berlin-Göttingen-Heidelberg: Springer 1951.
Unsicker, K.: Uber die Ganglienzellen im Nebennierenmark des Goldhamsters. Ein Beitrag zur Frage der peripheren Neurosekretion. Z. Zellforsch. 76, 187 (1967).
Biochemistry, Physiology and Pharmacology of the Catecholamines
Axelrod, J.: The metabolism, storage and release of catecholamines. Recent Progr. Hormone Res. 21, 597 (1965).
Axelrod, J., Baltzan, M.A., Andres, R., Cader, G., Zierler, K. L. : Effects of epinephrine on forearm blood flow and metabohsm in man. J. clin. Invest. 44, 80 (1965).
Belleau, B.: Steric effects in catecholamine interactions with enzymes and receptors. Pharmacol. Rev. 18, 131 (1965).
Belleau, B., Blaschko, H., Muscholl, E.(ed.): Catecholamines. Handbuch der experimentellen Pharmakologie, vol. 33. Berlin- Heidelberg-New York: Springer 1972.
Belleau, B., Braunwald, E., Harrison, D.C., Ciddsey, C. A.: The heart as an endocrine organ. Amer. J. Med. 36, 1 (1964).
Belleau, B., Burn, J. H.: Release of noradrenaline from the sympathetic postganghonic fibre. Brit. med. J. 1967 1, 197.
Belleau, B., Epstein, ST. E., Braunwald, E.: Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications. New Engl. J. Med. 275, 1106 (1966).
Belleau, B., Harrison, T. S., Chawla, R.C., Wojtalik, R. S.: Steroidal influences on catecholamines. New Engl. J. Med. 279, 136 (1968).
Belleau, B., Henkin, R. I., Bartter, F. C.: Urinary free and conjugated epinephrine and norepinephrine in normal subjects and in patients with various disorders. Fed. Proc. 24, 133 (1965).
Belleau, B., Hess, W. R.: Die funktionelle Organisation des vegetativen Nervensystems. Basel: Benno Schwabe 1948.
Belleau, B., Holtz, P.: Gewebs- und Neurohormone. 8. Symp. Dtsch. Ges. Endokr. Berlin-Göttingen-Heidelberg: Springer 1962.
Belleau, B., Holtz, P., Palm, D.: Brenzkatechinamine und andere sympathico- mimetische Amine. In: Ergebnisse der Physiologie, biologischen Chemie und experimentellen Pharmakologie, Bd. 58. Berhn-Heidelberg-New York: Springer 1966.
Belleau, B., Illig, R., Ziegler, W. H.: Glucose tolerance and immuno- reactive insulin in patients with pheochromocytoma: the effect of a-receptor blocking agents. Acta endocr. (Kbh.) 66, 368 (1971).
BELLEAU, B., IVERSEN, L.L. (ed.): Catecholamines. Brit. med. Bull. 29, 91 (1973).
Belleau, B., King, S. E., Baldwin, D. S.: Production of renal ischemia and proteinuria in men by the adrenal medullary hormones. Amer. J. Med. 20, 217 (1956).
Belleau, B., Kuschinsky, G., Süllmann, H.: Kurzes Lehrbuch der Pharmakologie. Berlin-Göttingen-Heidelberg: Springer 1964.
Belleau, B., Labhart, A., Scheitlin, W.: Niere bei Endokrinopathien. In: Handbuch der inneren Medizin, hrsg. von Schwiegk, Bd. 8,3. Teil, 5. Aufl. Berlin-Heidelberg-New York: Springer 1968.
Belleau, B., Langemann, H.: Pharmakologie des vegetativen Nervensystems. Akt. Fragen Psychiat. Neurol. 3, 74 (1966).
Belleau, B., Maccannell, K.L., Mcnay, J.L., Meyer, M.B., Goldberg, L. I.: Dopamine in the treatment of hypotension and shock. New Engl. J. Med. 275, 1389 (1966).
Belleau, B., Malmejac, J.: Activity of the adrenal medulla and its regulation. Phys. Rev. 44, 186 (1964).
Belleau, B., Mcdonald, R. H. JR., Goldberg, L. L, Mcnay, J. L., TUTTLE, E. P.: Effect of dopamine in man: augmentation of sodium excretion, glomerular filtration rate, and renal plasma flow. J. chn. Invest. 43, 1116 (1964).
Belleau, B., Mueller, C. B., Surtschin, A., Carlin, M. R., White, H. L.: Glomerular and tubular influences on sodium and water excretion. Amer. J. Physiol. 165, 411 (1951).
Belleau, B., Nickel, J. F., Mcsmythe, CH., Papper, E. M., Bradley, S. E.: A study of the mode of action of the adrenal medullary hormones on sodium, potassium and water excretion in man. J. clin. Invest. 33, 1687 (1954).
Pullman, T.N., Mcclure, W.W.: The effect of 1-nor- adrenaline on electrolyte excretion in normal man. J. Lab. clin. Med. 39, 711 (1952).
Reader, R.: Catecholamines in cardiovascular physiology and disease. New York: Amer. Heart Assoc., Inc. 1967.
Sandler, M.: Biosynthesis and metabolism of the catecholamines. Schweiz. med. Wschr. 100, 526 (1970).
SchüRMANN, H.J.: Speicherung und Freisetzung der Brenz- catechinamine. Gewebs- u. Neurohormone. 8. Symp. der Dtsch. Ges. Endocrin. Beriin-Göttingen-Heidelberg: Springer 1962.
Second Symposium on Catecholamines 1965. Pharmacol. Rev. 18, 1–804(1966).
Sutherland, E.W., Øye, I., Butcher, R.W.: The action of epinephrine and the role of the adenyl cyclase system in hormone action. Recent Progr. Hormone Res. 21, 623 (1965).
Sutherland, E.W., Robinson, A., Butcher, R.W.: Some aspects of the biological role of adenosine 3’,5’monophosphate (cyclic AMP). Circulation 37, 279 (1968).
SundÃN, T.: The effect of body posture on the urinary excretion of adrenaline and noradrenaline. Acta med. scand., Suppl. 336 (1958).
Thoenen, H.: Bildung und funktionelle Bedeutung adrener- ger Ersatztransmitter. Berhn-Heidelberg-New York: Springer 1969.
Vance, J. E., Buchanan, R. D., O’HARA, D., WILLIAMS, R. H., PORTE, D JR.: Insulin and glucagon responses in subjects with pheochromocytoma: effect of alpha adrenergic blockade. J. clin. Endocr. 29, 911 (1969).
Vogt, M.: Effects of drugs on metabolism of catecholamines in the brain. Brit. med. Bull. 21, 57 (1965).
Weiner, N.: The catecholamines: biosynthesis, storage and release, metabolism and metabolic effects. In: The hormones, ed. by PINCUS, THIMANN and ASTWOOD, vol. IV. New York and London: Academic Press 1964.
Wesson, L. G.: Hormonal influences on renal function. Ann. Rev. Med. 12, 77 (1961).
WILBER, J. F., TURTLE, J. R., CRANE, N. A.: Inhibition of insulin secretion by a phaeochromocytoma. Lancet 1966II, 733.
Wurtman, R.J.: Catecholamines. New Engl. J. Med. 273, 637, 693, 746 (1965).
Wurtman, R.J., Axelrod, J.: Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids. J. biol. Chem. 241, 2301 (1966).
Wurtman, R.J., Pohorecky, L. A.: Adrenocortical control of epinephrine synthesis in health and disease. Advanc. metabol. Disorders 5, 53 (1971).
Adrenal Medulla: Hypofunction
Broberger, O., ZetterströM, R.: Hypoglycemia with an inability to increase the epinephrine secretion in insulin- induced hypoglycemia. J. Pediat. 59, 215 (1961).
Brunjes, S H., Hodgman, J., Nowack, J., Johns, V.J.: Adrenal medullary function in idiopathic spontaneous hypoglycemia of infancy and childhood. Amer. J. Med. 34, 168 (1963).
Dancis, J., Smith, A.A.: Familial dysautonomia. New Engl. J. Med. 274, 207 (1966).
Euler, U. S. V., Ikkos, D., Luft, R.: Adrenaline excretion during resting conditions and after insuhn in adrenalectomized human subjects. Acta endocr. (Kbh.) 38,441 (1961).
Goldfien, A., Moore, R., Zileli, S., Havens, L. L., Boling, L., Thorn, G.W.: Plasma epinephrine and norepinephrine levels during insulin-induced hypoglycemia in man. J. clin. Endocr. 21, 196 (1961).
Goodall, M.C., Gitlow, S.E., Alton, H.: Decreased noradrenaline (norepinephrine) synthesis in familial dysautonomia. J. clin. Invest. 50, 2734 (1971).
Goodall, M.C., Haynes, B.W.: Adrenal medullary insufficiency in severe thermal burn. J. clin. Invest. 39, 1927 (1960).
Hickler, R.B., Wells, R.E., Tyler, H.R., Hamlin, J.T.: Plasma catecholamine and electroencephalographic responses to acute postural change. Amer. J. Med. 26, 410 (1959).
Luft, R., Euler, U. S. V.: Two cases of postural hypotension showing a deficiency in release of nor-epinephrine and epinephrine. J. clin. Invest. 32, 1065 (1953).
Mark, G.: Die idiopathische orthostatische Hypotonie. Schweiz. med. Wschr. 99, 1877 (1969).
Slaton, P. E JR., Biglieri, E. G.: Reduced aldosterone excretion in patients with autonomic insufficiency. J. clin. Endocr. 27, 37 (1967).
Smith, A. A., Taylor, T., Wortis, S. B.: Abnormal catecholamine metabolism in familial dysautonomia. New Engl. J. Med. 268, 705 (1963).
Tietze, H. U., ZurbrüGG, R. P., Zuppinger, K. A., Joss, E. E., Kä;ser, H.: Occurrence of impaired Cortisol regulation in children with hypoglycemia associated with adrenal medullary hyporesponsiveness. J. clin. Endocr. 34, 948 (1972).
Käser, H.: Die Kortisolregulation bei kindlichen Hypoglykämien mit Nebennierenmark-Dysregulation. Schweiz, med. Wschr. 100, 545 (1970).
Völlm, K., Schaue, F.: Zur sogenannten „Postural Hypotension“. Lageabhängige Hypotonie bei idiopathischer Störung der neurovegetativen Kreislaufregulation. Schweiz, med. Wschr. 94, 33 (1964).
Weinshilboum, R. M., Axelrod, J.: Reduced plasma dop- amine-j?-hydroxylase activity in familial dysautonomia. New Engl. J. Med. 285, 938 (1971).
Pheochromocytoma
Grout, J.R.: Pheochromocytoma. Pharmacol. Rev. 18, 651 (1966).
Greer, W. E. R., Robertson, GH. W., Smithwick, R. H.: Pheochromocytoma. Diagnosis, operative experiences and chnical resuhs. Amer. J. Surg. 107 192 (1964).
Hermann, H., Mornex, R.: Les phéochromocytomes. Etude clinique et physiopathologique des tumeurs humaines sécrétants des catécholamines. Paris: Gauthier-Villars 1964.
Hillestad, L., Brodwall, E.: Pheochromocytoma. A review of clinical findings in 10 cases. Acta med. scand. 187, 313 (1970).
Hume, D.M.: Phaeochromocytomas in the adult and in the child. Amer. J. Surg. 99, 458 (1960).
HUME, D.M.: Phaeochromocytoma. In: Clinical endocrinology, vol. II, ed. by ASTWOOD and CASSIDY. New York/London: Grune & Stratton 1968.
Sack, H., Koll, J. F.: Das Phäochromocytom. Ergebn. inn. Med. Kinderheilk. 19, 446 (1963).
Schwarz, K.: Das Phäochromocytom. Internist (Berl.) 5, 22 (1964).
Ziegler, W. H., Langemann, H., Müller, P. B.: Vergleichende Untersuchungen an Tumorgewebe von Phaeochromo- cytom und Carcinoid. Schweiz. med. Wschr. 97, 1731 (1967).
Pathological Anatomy
BRINES, O.A., JENNINGS, E.R.: Paraganghomas. Review of subject and report of 5 original cases. Amer. J. Path. 24, 1167(1948).
Dietrich, A., Siegmund, H.: Die Nebennieren und das chromafTine System (Paraganglien, Carotisdriise, Steißdrüse). In: F. HenkeU. O. Lubarsch, Handbuch der speziellen pathologischen Anatomie, Bd. 8, p. 951. Berlin: Springer 1926.
Graham, J.B.: Pheochromocytoma and hypertension: An analysis of 207 cases. Int. Abstr. Surg. 92, 105 (1951).
Karsner, H.T.: Tumors of the adrenal. In: Atlas of tumor pathology, Sect. VIII, Fasc. 29. Washington, D. C.: Armed Forces Inst, of Path. 1950.
Liebegott, G.: Studien zur Orthologie und Pathologie der Nebennieren. Beitr. path. Anat. 109, 93 (1947).
Liebegott,G.: Die Pathologie der Nebennieren. Verh. dtsch. path. Ges. 36, 21 (1952).
Symington, TH.: Functional pathology of the human adrenal gland. Edinburgh-London: Livingston Ltd. 1969.
Zollinger, H.U.: Nieren Veränderungen bei Phäochromocytom. Schweiz, med. Wschr. 89, 841 (1959).
Clinical Aspects and Therapy of the Paroxysmal and Persisting Hypertension
BAIRD, J.M., COHEN, H.: Pheochromocytoma: A case with hypotension, paroxysmal hypertension and urinary retention. Lancet 1954II, 270.
Bellas, J.E.: Nonsurgical pheochromocytomas. J. Amer. med. Ass. 185, 601 (1963).
Brunjes, S., Johns, V.J JR., Crane, M.G.: Phaeochromocytoma. Postoperative shock and blood volume. New Engl. J. Med. 262, 393 (1960).
Buchborn, E.: Klinische Pathophysiologic der Hamkonzentrierung. Schweiz. med. Wschr. 94, 1273 (1964).
Cahill, G.F.: Pheochromocytomas. J. Amer. med. Ass. 138, 180 (1948).
Crandell, D. L., Myers, R.T.: Phaeochromocytoma. Anesthetic and surgical considerations. J. Amer. med. Ass. 187, 12 (1964).
Crout, J.R., Sjoerdsma, A.: Turnover and metabohsm of catecholamines in patients with pheochromocytoma. J. clin. Invest. 43, 94 (1964).
Dahl-IVERSEN, E.: 18 Phaeochromocytomas. Clinical aspects and surgical results. Acta chir. scand. 116, 118 (1959).
Drukker, W, Formeijne, P., Schoot, J. B VAN DER:Hyper- plasia of the adrenal medulla. Brit. med. J. 1957 1, 186.
Engelman, K., Horwitz, D., Jéquier, E., Sjoerdsma, A.: Biochemical and pharmacologic effects of a-methyl- tyrosine in man. J. chn. Invest. 47, 577 (1968).
Engelman, K., Mueller, P. S., Sjoerdsma, A.: Elevated plasma free fatty acid concentrations in patients with pheochromocytoma. New Engl. J. Med. 270, 865 (1964).
Engelman, K., Sjoerdsma, A.: Chronic medical therapy for pheochromocytoma. Ann. intern. Med. 61, 229 (1964).
Fertig, H.A., Taylor, R.D., Corcoran, A.C, Page, LH.: The renal manifestations of phaeochromocytoma. Report of a case. Ann. intern. Med. 35, 1358 (1951).
Gifford, R.W JR., Kvale, W.F., Maher, F.T., Roth, G.M., Priestley, J. T.: Clinical features, diagnosis and treatment of pheochromocytoma: a review of 76 cases. Proc. Mayo Clin. 39, 281 (1964).
Graham, J.B.: Pheochromocytoma and hypertension. An analysis of 207 cases. Int. Abstr. Surg. 92, 105 (1951).
Green, D. M.: Phaeochromocytoma and chronic hypertension. J. Amer. med. Ass. 131, 1260 (1946).
Harrison, J. H., Gardner, F. H., Dammin, G.J.: A note on pheochromocytoma and renal hypertension. J. Urol. (Baltimore) 79, 173 (1958).
Koll, J. F., Sack, H.: Besonderheiten des Kreislaufverhaltens bei Phaeochromocytomen mit Dauerhochdruck. Münch, med. Wschr. 104, 655 (1962).
Kvale, W.F., Roth, G.M., Manger, W.M., Priestley, J.T: Pheochromocytoma. Circulation 14, 622 (1956).
LABHART, A., SCHEITLIN, W.: Niere bei Endokrinopathien. In: Handbuch der inneren Medizin, ed. by SCHWIEGK, Bd. 8,3. Teil, 5th ed. Berlin-Heidelberg-New York: Springer 1968.
Mathison, D. A., Waterhouse, C. A.: Cushing’s syndrome with hypertensive crisis and mixed adrenal cortical adenoma-pheochromocytoma (corticomedullary adenoma). Amer. J. Med. 47, 635 (1969).
Megevand, R., Schneiter, R.: Un cas de pheochromocy- tome extrasurrenahen droit ä Symptomatologie essentiel- lement digestive et douloureuse. Schweiz. med. Wschr. 13, 498 (1963).
Montalbano, F. P., Baronofsky, I. D., Ball, H.: Hyperplasia of the adrenal medulla. A clinical entity. J. Amer. med. Ass. 182, 164 (1962).
Rosenheim, M.L., Ross, E.J., Wrong, O.M., Hodson, C.J., Davies, D.R., Smith, J.F.: Unilateral renal ischemia due to compression of a renal artery by a pheochromocytoma. Amer. J. Med. 34, 735 (1963).
Sack, H., Koll, J.F.: Das Phäochromocytom. Ergebn. inn. Med. Kinderheilk. 19, 446 (1963).
SJOERDSMA, A., ENGELMAN, K., SPECTOR, S., UDENFRIEND, S.: Inhibition of catecholamine synthesis in man with alpha- methyl-tyrosine, an inhibitor of tyrosine hydroxylase. Lancet 1965n, 1092.
Smithwick, R. H., Greer, W.E., Robertson, C. W., Wilkins, R.W.: Phaeochromocytoma. New Engl. J. Med. 242, 252 (1950).
Spergel, G., Bleicher, S. J., Ertel, N. H.: Carbohydrate and fat metabolism in patients with pheochromocytoma. New Engl. J. Med. 278, 803 (1968).
Thomas, J.E., Rooke, D., Kvale, W.F.: The neurologists experience with pheochromocytoma. J. Amer. med. Ass. 197, 754 (1966).
Vliet, P.D. VAN, Burchell, H.B., Titus, J.L’.: Focal myocarditis with pheochromocytoma. New Engl. J. Med. 274, 1102 (1966).
Weidmann,P., Siegenthaler, W., Ziegler, W. H., Sulser, H., Endres, P., Werning, C.: Hypertension associated with tumors adjacent to renal arteries. Amer. J. Med. 47, 528 (1969).
WILBER,J.F., TURTLE,J.R., CRANE,N.A.: Inhibition of insulin secretion by a phaeochromocytoma. Lancet 1966II, 733.
Ziegler, W, Labhart, A., Frick, P.: Schockverhütung beim Phäochromocytom durch präoperative Behandlung mit einem Rezeptorenblocker. Bibl. cardiol. (Basel) 17, 1 (1966).
Zollinger, H. U.: Nieren Veränderungen bei Phäochromocytom. Schweiz, med. Wschr. 89, 841 (1959).
Hypotension
Kahn, M.T., Mullon, D.A.: Pheochromocytoma without hypertension. J. Amer. med. Ass. 188, 74 (1964).
Loizeau, E.: A propos d’un cas de phéochromocytome avec hypotension artérielle. Schweiz. med. Wschr. 94, 926 (1964).
Louis, W.J., Doyle, A.E., Hearth, W.C., Robinson, M.J.: Secretion of Dopa in phalochromocytoma. Brit. med. J. 4, 325 (1972).
Page, L.B., Raker, J.W., Berberich, F. R.: Pheochromocytoma with predominant epinephrine secretion. Amer. J. Med. 47, 648 (1969).
RICHMOND,J., FRAZER,S.C., MILLAR,D.R.: Paroxysmal hypotension due to an adrenaline-secreting phaeochromocytoma. Lancet 1961II, 904.
Malignant Pheochromocytomas
Forsell, J., Malm, P.: Recurrent pheochromocytoma. Acta med. scand. 163, 55 (1959).
Käser, H.: Catecholamine-producing neural tumors other than pheochromocytoma. Pharmacol. Rev. 18,659 (1966).
Käser, H., Türler, K., Burri, M.C.: Zum Katecholaminstoffwechsel im Gewebe maligner und benigner Tumoren des sympathischen Nervensystems. Schweiz, med. Wschr. 101, 484 (1971).
Karlson, P., Sekeris, C.E., Herrlich, P.: Über neue Dopaminmetaboliten im Harn beim bösartigen Phäochromocytom. Dtsch. med. Wschr. 39, 1873 (1963).
Palmieri, G., Ikkos, D., Luft, R.: Malignant phaeochromocytoma. Acta endocr. (Kbh.) 36,549 (1961).
Sheps, S.G., Kottke, B.A., Tyce, G.M., Flock, E.V.: Effect of methyldopa on the metabolism of catecholamines and tryptophan in metastatic pheochromocytoma. Amer. J. Cardiol. 14, 641 (1964).
Special Forms and Combinations with Other Syndromes
CuNLiFFE,W.J., BLACK, M.N., HALL, R., JOHNSTON, J. D. A., HUDGSON,P., SHUSTER,S., GUDMUNSSON, P.V., JOPLIN, G. F., WILLIAMS, E. D., WOODHOUSE, N. J. Y, GALANTE, L., MAC INTYRE, J.: A calcitonin-secreting thyroid carcinoma. Lancet 1968II, 63.
Cushman, P JR.: Familial endocrine tumors. Report of two unrelated kindred affected with pheochromocytomas, one also with multiple thyroid carcinomas. Amer. J. Med. 32, 352 (1962).
Duke, W. M., Phillips, M. W, Donals, J. M., Boshell, B. R.: A norepinephrine-secreting glomic tissue tumor (Che- modectoma). J. Amer. med. Ass. 193, 20 (1965).
Garnier, B., Gertsch, R.: Autonome Hyperreflexie und Katecholaminausscheidung beim Paraplegiker. Schweiz. med. Wschr. 94,124(1964).
Glushien, A. S., Mansuy, M.M., Littman, D. S.: Pheochromocytoma. Its relationship to the neurocutaneous syndromes. Amer. J. Med. 14, 318 (1953).
Huang, S., Mcleish, W. A,: Pheochromocytoma and medullary carcinoma of thyroid. Cancer (Philad.) 21,302 (1968).
Keynes, W.M., Till, A. S.: Medullary carcinoma of the thyroid gland. Quart. J. Med., N.S. 40, 443 (1971).
Leading article: Phaeochromocytoma and thyroid cancer. Brit. med. J. l%5n, 549.
Levit, S.A., Sheps, S.G., Espinosa, R. E., Remine, W.H., Harrison, E.G JR.: Catecholamine-secreting paraganglioma of glomus-jugulare region resembling pheochromocytoma. New Engl. J. Med. 281, 805 (1969).
LJUNGBERG, O., CEDERQUIST, E., STUDNITZ, W. V.: Medullary thyroid carcinoma and phaeochromocytoma: a familial chromaffmomatosis. Brit. med. J. 19671, 279.
Mathys, S., Ziegler, W.H., Francke, C.: Bilaterales Phäochromozytom — medulläres Schilddrüsenkarzinom mit Cushing-Syndrom. Schweiz, med. Wschr. 102, 798 (1972).
Melvin, K.E.B., Tashjian, A.H JR.: The syndrome of excessive thyrocalcitonin produced by medullary carcinoma of the thyroid. Proc. nat. Acad. Sci. (Wash.) 59, 1216 (1968).
NagantDE DEUXCHAISNES, C.,Fanconi, A., Alberto, P., RUDLER,J.C., MACH, R.S.: Phéochromocytomes extra-surrénaliens multiples avec «dystrophic d’Albright» et hémiangiomes cutanés. Schweiz. med. Wschr. 90, 886 (1960).
Rossier, A. B., Ziegler, W. H., Duchosal, P. W., Meylan, J.: Fonction sexuelle, dysréflexie autonome et catéchol- amines dans les lésions médullaires traumatiques. Schweiz. med. Wschr. 101, 784 (1971).
Sapira, J.S., Altman, M., Vandyk, K., Shapiro, A. P.: Bilateral adrenal pheochromocytoma and medullary thyroid carcinoma. New Engl. J. Med. 273, 140 (1965).
Schimke, R.N., Hartmann, W. H., Prout, T.E., Rimoin, D.L.: Pheochromocytoma, medullary thyroid carcinoma and multiple neuromas. New Engl. J. Med. 279,1 (1968).
Schlegel, G. G.: Neurofibromatose Recklinghausen und Phäochromocytom. Schweiz, med. Wschr. 90, 31 (1960).
Steiner, H. L., Goodman, A. D., Powers, S. R.: Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing’s disease: multiple endocrinopathia type 2. Medicine (Baltimore) 47, 371 (1968).
Streit, W., Baumann, R. P.: Phaochromocytom-Ganglio- neurom-Fibrosarkom. Schweiz. med. Wschr. 97, 1152 (1967).
Tisherman, S.E., Gregg, F.J., Danowski, T. S.: Famihal phaeochromocytoma. J. Amer. med. Ass. 182, 152 (1962).
Williams, E. D.: Histogenesis of medullary carcinoma of the thyroid. J. chn. Path. 19, 114 (1966).
Williams, E. D. Pollock, D. J.: Muhiple mucosal neuromata with endocrine tumours: a syndrome ahied to von Recklinghausen’s disease. J. Path. Bact. 91, 71 (1966).
Diagnosis
Engelman, K., Sjoerdsma, A.: A new test for phaeochromocytoma. Pressor responsiveness to Tyramine. J. Amer. med. Ass. 189, 81 (1964).
Feyrter,F.: Ein adrenolipoides Syndrom: Normologie und Pathologie des braunen Fettgewebes. Wien. klin. Wschr. 83, 393 (1971).
Gitlow, S.E., Mendlowitz, M., Khassis, S., Cohen, G., Stra, J.: The diagnosis of pheochromocytoma by determination of urinary 3-methoxy, 4-hydroxymandehc acid. J. clin. Invest. 39, 211 (1960).
Jéquier, E.: Mesure biochimique de la fonction de la médullosurrénale et du système sympathique en chni- que. Schweiz. med. Wschr. 100, 532 (1970).
Käser, H.: Die Bedeutung der 3-Methoxy-4-Hydroxy-Man- delsäure (MHMS) für die Differentialdiagnostik neuraler Tumoren im Kindesalter. Schweiz, med. Wschr. 91, 586 (1961).
Käser, H. : Biochemische Diagnostik des Phäochromocytoms, des Neuroblastoms und anderer neuro-ektodermaler Neoplasien. Helv. paediat. Acta, Suppl. 29 (1972).
Käser, H. : Catecholamine-producing neural tumors other than pheochromocytoma. Pharmacol. Rev. 18, 659 (1966).
Lawrence, A. M.: Glucagon provocative test for pheochromocytoma. Ann. intern. Med. 66, 1091 (1967).
LEFEBVRE, P. J., CESSIONFOSSION, A., LUYCKX, A.S.: Glucagon test for pheochromocytoma. Lancet 1966 II, 1366.
LEIPHART, CH.J., NUDELMAN, E.J. : Hibernoma masquerading as a pheochromocytoma: case report. Radiology 95, 659(1970).
Pisano, J.J., Grout, J.R., Abraham, D.: Determination of 3-methoxy-4-hydroxymandelic acid in urine. Clin. chim. Acta 7, 285 (1962).
Rossi, P., Young, J.S., PANKE,W.F.: Techniques, usefullness and hazards of arteriography of pheochromocytoma. J. Amer. med. Ass. 205, 547 (1968).
Roth, G. M., Flock, E. V., Kvale, W. F., Waugh, J. M., Ogg, J.: Pharmacologic and chemical test as an aid in the diagnosis of pheochromocytoma. Circulation 21, 769 (1960).
Sato, T.L., Sjoerdsma, A.: Urinary homovanillic acid in phaeochromocytoma. Brit. med. J. 1965 II, 1472.
Sheps, SH.G., Maher, F.T.: Comparison of the histamine and tyramine tests in the diagnosis of pheochromocytoma. J. Amer. med. Ass. 195, 265 (1966).
Sheps, SH.G., Maher, F.T. Histaminand glucagon tests in diagnosis of pheochromocytoma. J. Amer. med. Ass. 205, 895 (1968).
Spengler,G. A., Käser, H., Riva,G.: Die Bestimmung von Metanephrin und Normetanephrin im Urin. Schweiz. med. Wschr. 93,1684(1963).
Studnitz, W. VON: Glukagontest und Phäochromozytom- diagnostik. Schweiz. med. Wschr. 100, 1023 (1970).
Studnitz, W., Käser, H., Sjoerdsma, A.: Spectrum of catechol amine biochemistry in patients with neuroblastoma. New Engl. J. Med. 269, 232 (1963).
Studnitz, W.,Ljungberg, O.: Tyramine test and phaeochromocytoma. Acta med. scand. 182, 341 (1967).
Swart, B.: Die röntgenologische Diagnose des Phaeochro- mocytoms. Dtsch. med. Wschr. 89, 2335 (1964).
Vendsalu, A.: Studies on adrenaline and noradrenaline in human plasma. Acta physiol. scand. 49, Suppl. 173 (1960).
Ziegler, W.: Die Bedeutung der Vanillin-Mandelsäure (VMS) für die Diagnostik des Phaeochromocytoms und für die Untersuchung des Katecholamin-Stoffwechsels. Helv. med. Acta 27, 647 (1960).
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Labhart, A. (1974). The Adrenal Medulla. In: Clinical Endocrinology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-96158-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-96158-8_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-96160-1
Online ISBN: 978-3-642-96158-8
eBook Packages: Springer Book Archive